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Abstract
Introduction: The expanding HIV epidemic in Azerbaijan and Kyrgyzstan is concentrated among people who inject drugs
(PWID), who comprise a third of prisoners there. Detention of PWID is common but its impact on health has not been previously
studied in the region. We aimed to understand the relationship between official and unofficial (police harassment) detention
of PWID and HIV risk behaviours.
Methods: In a nationally representative cross-sectional study, soon-to-be released prisoners in Kyrgyzstan (N368) and
Azerbaijan (N510) completed standardized health assessment surveys. After identifying correlated variables through bivariate
testing, we built multi-group path models with pre-incarceration official and unofficial detention as exogenous variables
and pre-incarceration composite HIV risk as an endogenous variable, controlling for potential confounders and estimating
indirect effects.
Results: Overall, 463 (51%) prisoners reported at least one detention in the year before incarceration with an average of
1.3 detentions in that period. Unofficial detentions (13%) were less common than official detentions (41%). Optimal model fit
was achieved (X25.83, p0.44; Goodness of Fit Index (GFI) GFI0.99; Comparative Fit Index (CFI) CFI1.00; Root Mean
Square Error of Approximation (RMSEA) RMSEA0.00; PCLOSE0.98) when unofficial detention had an indirect effect on HIV
risk, mediated by drug addiction severity, with more detentions associated with higher addiction severity, which in turn
correlated with increased HIV risk. The final model explained 35% of the variance in the outcome. The effect was maintained for
both countries, but stronger for Kyrgyzstan. The model also holds for Kyrgyzstan using unique data on within-prison drug
injection as the outcome, which was frequent in prisoners there.
Conclusions: Detention by police is a strong correlate of addiction severity, which mediates its effect on HIV risk behaviour. This
pattern suggests that police may target drug users and that such harassment may result in an increase in HIV risk-taking
behaviours, primarily because of the continued drug use within prisons. These findings highlight the important negative role that
police play in the HIV epidemic response and point to the urgent need for interventions to reduce police harassment, in parallel
with interventions to reduce HIV transmission within and outside of prison.
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Introduction
Despite marked declines globally, HIV incidence and mortality
continue to rise in Central Asia and the Southern Caucuses 
two neighbouring regions comprised of former Soviet Union
(FSU) states [1]. People who inject drugs (PWID) are re-
sponsible for approximately 70% of new HIV infections in
Central Asia [2]. The scenario in the Southern Caucuses is
more mixed, but injection accounts for over half of all HIV
transmission in Azerbaijan and Georgia, two of the region’s
three countries [3]. Kyrgyzstan and Azerbaijan are represen-
tative of Central Asia and the Southern Caucuses, respec-
tively, with epidemics that are highly concentrated among at-
risk populations, in particular PWID [4]. At 32.4%, Kyrgyzstan
has the highest upper estimate of HIV prevalence in PWID
in the region. In Azerbaijan, HIV prevalence among PWID
ranges between 19 and 24% [5]. Throughout Central Asia
and the Southern Caucuses, opioids are the primary drugs
injected, likely due to their availability from heroin trafficking
originating in nearby Afghanistan [6].
One of the major global challenges to addressing the HIV
epidemic among PWID has been the legal environment facing
PWID, specifically the criminalization of drug possession, use
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and addiction [711]. Policing practices play a major role in
constructing this ‘‘risk environment’’ [10,12] promoting risky
behaviour such as rushed injection [13,14], overdose [15],
use of non-sterile syringes [13,16], and undermining uptake
of and adherence to increasingly available evidence-based
options for the prevention of HIV transmission among PWID,
such as needle-syringe programmes (NSP), opioid agonist
therapies (OAT) with methadone or buprenorphine, and
antiretroviral therapy (ART) [1720]. Policing practices that
affect PWID include targeted enforcement at treatment
facilities [21,22], intimidation of providers [23,24] and syringe
confiscation [25]. Particularly damaging may be unofficial
detention of PWID (involving no formal charges and often
undertaken outside the scope of the law), which can be
conceptualized as a form of police harassment. A recent
study in Ukraine found this practice to be common, often
resulting in opioid withdrawal and prolonged interruptions of
ART and OAT [17].
In Central Asia and the Southern Caucuses, arrests and
detentions of PWID, both official and unofficial, are common
[10,2629]. Neither the prevalence of unofficial detention of
PWID nor its impact on health, however, has been examined in
these regions.This study aims to understand the prevalence of
pre-incarceration police detention among nationally repre-
sentative incarcerated PWID, as well as the comparative
impact of official and unofficial detention on PWID HIV risk
behaviour, such as unprotected sex and use of non-sterile
injection equipment in Kyrgyzstan and Azerbaijan. The focal
research question here is whether police target PWID and
whether such targeting is associated with increased HIV risk-
taking behaviours.
Methods
The sampling, inclusion criteria and survey methods with sur-
vey content have been previously described [29,30]. Briefly,
a nationally representative biobehavioural health survey of
prisoners within six months of release was conducted from
February to November 2014. Eligible adult prisoners were
randomly sampled from 8 prisons in Kyrgyzstan (N368) and
from 13 prisons in Azerbaijan (N510). They completed
confidential, self-administered surveys assessing HIV risk,
health status and criminal justice involvement using audio-
computer-assisted self-survey instruments (ACASI) on touch-
screen laptop computers [31] to ensure anonymity, minimize
social desirability bias, and facilitate ethical principles of
conducting research with prison populations [32]. Partici-
pants were randomly selected from all sentenced prisoners
within six months of release in non-specialized facilities in
both countries using a stratified random sampling scheme
[33] previously validated in Eastern Europe and Central Asia
[29,30,34]. Inclusion criteria for participation included (1)
]18 years, (2) currently serving a sentence in a non-
specialized facility and (3) scheduled to be released within six
months. Specialized facilities (juvenile detention and hospital
prisons) and pre-trial detention centres were not included.
Experienced research assistants (RAs) from local NGOs that
work with prisoners underwent extensive training on study
methods and confidentiality procedures. They used a random
assignment chart to select participants who were informed
by prison staff that they were randomly selected for par-
ticipation in a voluntary and anonymous health study. The
enrolment was kept proportional to the number of prisoners
within six months of release in each country (50% for
Azerbaijan and 40% for Kyrgyzstan). From an estimated
1037 inmates in non-specialized facilities meeting eligibility
criteria in Azerbaijan, 535 were selected, and 25 (4.7%)
refused participation. The eligible sample size in Kyrgyzstan
was 938 inmates, and among 381 selected participants, 13
(3.4%) did not provide informed consent.
Study measures
Surveys were originally constructed in English, translated into
Russian, Azeri and Kyrgyz languages, back translated into
English [35], reviewed by bilingual researchers and piloted to
ensure clarity, quality and respondents’ comprehension. In
addition to demographic characteristics, the 10-item Clinical
Epidemiological Survey of Depression (CES-D 10) [36]; Zung
anxiety scale [37]; and WHO’s Alcohol Use Disorders Inven-
tory Test (AUDIT) [38] were included. The Addiction Severity
Index  Lite Version [39] was used to measure addiction
severity.
HIV risk behaviours were measured using an adapted set of
items from NIDA’s Risk Behavior Assessment (RBA) addres-
sing sexual and drug risk-taking behaviours in the
30-day period prior to the arrest that resulted in the current
incarceration. Sexual risk was measured by frequency of
unprotected sex events, and drug risk was measured by the
number of injection days multiplied by the average number
of injections per day using non-sterile injection equipment.
The sum of these items formed a composite measure, HIV
Risk [40]. Noteworthy, in Kyrgyzstan, due to more lenient
regulations, relative to the ones that exist in Azerbaijan,
which did not require reporting drug use to the prison
department, questions about within-prison injection-related
risk behaviours were assessed during the survey. This
provided a unique opportunity to measure current within-
prison drug injection (WPDI) [30]. WPDI was measured as
a binary response to whether or not injection occurred
during the current incarceration. Social support was mea-
sured using the Multidimensional Scale of Perceived Social
Support [41].
Detention measures
Detention was defined as an event of being detained in police
lock-up the year before incarceration when that event did not
lead to the current incarceration. Using previously defined
measures [17], detention history consisted of two measures
asking respondents to report the number of official and un-
official detentions in the year before the current incarceration.
An official detention was defined as detention accompanied
by formal charges, whereas an unofficial detention was de-
fined as detention not accompanied by a charge (e.g. drug
possession, theft). Based on previous research in the region,
unofficial detentions are considered a form of police harass-
ment [17]. The sum of these two items served as the
composite measure of detention. Further, respondents were
asked about each of the following adverse effects during their
unofficial and/or official detention: symptoms of abstinence
syndrome (withdrawal from opioids), interruption of HIV and
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OATmedications for more than 24 hours, and inability to see a
medical provider if needed. Respondents were also asked
whether their drug use, access to OAT, HIV or TB treatment
was used to extract a confession, and whether they were
stopped, searched, held or arrested while traveling to or from
a NSP site.
Data analysis
To guide our analysis, we hypothesized that police may
selectively target PWID and that such harassment practices
may translate into increased HIV risk behaviours. Hence, the
focal interest in the analyses was the relative association of
official and unofficial detention with drug addiction severity
and with the outcomes: HIV risk behaviours and WPDI.
For the cross-cultural analysis between the two countries,
the primary outcome measure was HIV risk, while for the
Kyrgyzstan sub-analysis, the primary outcome was current
WPDI, which measures present time injection and therefore
provides a unique opportunity to establish temporal ordering
in our cross-sectional data.
SPSS, version 22, was used to compute correlation and mul-
tiple regressions to assess multivariate relationships among
the variables. Non-parametric x2 tests and independent
sample t-tests were utilized to measure differences between
detained and not detained participants on each of the
described measures. The structural equation modelling pro-
gramme AMOS.22 was utilized to perform a multi-group path
analysis. To calculate indirect effects and investigate potential
mediating relationships among the variables in the model, we
used the AMOS bootstrapping procedure [42], a recom-
mended analytic strategy for avoiding measurement error
and underestimation of the mediation significance [43].
Ethics statement
Institutional Review Boards at Yale University, the Ukrainian
Institute on Public Health Policy and the Kyrgyzstan Ministry
of Health approved the study. Further ethical and safety
assurances were provided by the Office for Human Research
Protections (OHRP) in accordance with 45 CFR 46.305(c)
‘‘Prisoner Research Certification’’ requirements. Participants
provided written informed consent prior to study participation.
Results
Tables 1 and 2 provide descriptive statistics for detained
and not detained prisoners in the year before their current
incarceration in Kyrgyzstan and Azerbaijan, respectively.
The prevalence of recent detention was 51.5% in Kyrgyzstan
and 34% in Azerbaijan. In both countries, detained par-
ticipants reported higher average prison sentences, more
years in prison, lower age of first incarceration and higher
frequency of unprotected sex relative to prisoners who had
not been detained. In Kyrgyzstan, injection within the current
incarceration was higher among detained than not detained
prisoners. In Azerbaijan, detained prisoners reported higher
instances of injection and polysubstance use, as well as
higher levels of social support. Table 3 provides details on
experiences associated with official and unofficial detention
among detained prisoners in both countries.
Importantly, there was no difference between PWID and
people who did not inject drugs in their experiences with
official detention (t1.32, p0.18 for both countries), but
there was a difference in reports of unofficial detention.
Specifically, PWID experienced significantly higher unofficial
detention by police relative to people who did not inject
drugs in Azerbaijan (M0.22, SD0.72 vs. 0.05, SD0.26,
t2.76, p0.01) but not in Kyrgyzstan (t1.83, p0.07).
Effects of detention in Azerbaijan and Kyrgyzstan
The inter-correlation between official and unofficial deten-
tion was weak, but significant (r0.19), and both detention
variables differed in significance and magnitude in their asso-
ciation with drug addiction severity and HIV risk (Table 4).
To explore the relative effects of detention on HIV risk-taking
and investigate potential mediating relationships among the
variables identified as significant correlates through bivariate
testing while also accounting for moderating impact of each
country, we performed a multi-group path analysis with official
and unofficial detention as exogenous variables, addiction
Table 1. Comparison of detained and not detained participant characteristics in Kyrgyzstan (N355)
Characteristics Valid N Total n (%) Not detained n (%) Detained n (%) p*
Mean age (SD) 352 37.6 (11.3) 37.3 (11.2) 38.0 (11.4) 0.561
Male gender 353 273 (77.3) 107 (68.6) 166 (84.3) 0.001
Mean prison sentences before this incarceration (SD) 220 3.5 (2.2) 1.69 (2.2) 2.53 (2.6) 0.001
Mean lifetime years in prison (SD) 353 8.2 (6.9) 6.5 (5.5) 9.6 (7.5) B0.001
Mean age of first incarceration (SD) 353 26.2 (11.2) 29.0 (9.9) 24.0 (12.1) B0.001
Alcohol dependence in the year before this incarceration 352 150 (42.6) 58 (37.2) 92 (46.9) 0.082
ASI drug use composite score (SD) 350 0.08 (0.09) 0.07 (0.01) 0.08 (0.09) 0.177
Injected during current incarceration 353 69 (19.3) 21 (13.5) 47 (23.9) 0.015
Sexual intercourse without condom in 30 days before incarceration 352 175 (49.7) 72 (46.2) 103 (52.6) 0.139
Mean episodes (unprotected sex) 175 4.2 (7.7) 3.0 (6.5) 5.1 (8.4) 0.013
Moderate to severe symptoms of depression 353 118 (33.4) 58 (37.2) 60 (30.5) 0.212
Social support 355 2.8 (1.0) 2.8 (0.9) 2.8 (1.0) 0.654
Anxiety disorder 353 22 (6.2) 9 (5.8) 13 (6.6) 0.827
*Compares detained vs. not detained. Significance defined as pB0.05, and marked in bold.
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severity as a mediator, and composite HIV risk as an endo-
genous variable. We controlled for depression, anxiety, social
support and the presence of alcohol use disorders and
estimated indirect effects via bootstrapping procedures,
while step-wise eliminating insignificant paths and ‘‘hanging’’
variables.
Optimal model fit was achieved (X25.83, p0.44;
GFI0.99; CFI1.00; RMSEA0.00; PCLOSE0.98) when
unofficial detention had an indirect effect on HIV risk, fully
mediated by drug addiction severity, with more detentions
associated with higher drug addiction severity  in turn
correlating with increased HIV risk-taking behaviours. There
were two significant covariates in the model (Table 5). The
multi-group model with an identical path structure was a
good fit to the data as well (X21.98, p0.37; GFI0.99;
CFI1.00; RMSEA0.00; PCLOSE0.84). Our final aggre-
gate model is presented in Figure 1, and the multi-group
moderated mediation results with indirect, direct and total
effects for both countries presented in Table 6. For both
countries, addiction severity fully mediated the effect of
unofficial detention on HIV risk, whereby unofficial detention
was positively associated with addiction severity that in turn
was positively associated with HIV risk-taking behaviours.
Both the association between addiction severity and HIV
risk, and the indirect effect from unofficial detention to HIV
risk, were higher in Kyrgyzstan. The final model explained
Table 2. Comparison of detained and not detained participant characteristics in Azerbaijan (N496)
Characteristics Valid N Total. n (%) Not detained n (%) Detained n (%) p*
Mean age (SD) 496 38.2 (8.9) 38.3 (8.7) 37.6 (9.1) 0.404
Male gender 496 447 (90.1) 319 (97.6) 128 (75.7) B0.001
Mean prison sentences before this incarceration (SD) 152 1.6 (0.7) 1.5 (0.7) 1.8 (0.7) 0.005
Mean lifetime years in prison (SD) 496 4.6 (3.8) 3.7 (0.2) 3.8 (0.3) 0.002
Mean age of first incarceration (SD) 487 30.1 (8.8) 30.7 (8.8) 28.8 (8.6) 0.023
Alcohol dependence in the year before this incarceration 496 50 (10.2) 29 (8.9) 21 (12.7) 0.209
ASI drug use composite score (SD) 482 0.06 (0.04) 0.06 (0.04) 0.07 (0.05) 0.116
Ever injected drugs 496 157 (31.7) 100 (30.6) 57 (33.7) 0.478
Substance use in 30 days before this incarceration 466 166 (35.6) 105 (32.8) 61 (41.8) 0.076
30 or more injections 131 24 (18.3) 11 (12.6) 13 (29.5) 0.030
Used more than one substance 496 38 (7.7) 16 (4.9) 22 (13.0) 0.002
Sexual intercourse without condom in 30 days before incarceration 495 176 (35.5) 102 (31.3) 74 (43.8) 0.007
Mean episodes (unprotected sex) 176 16.7 (13.2) 0.06 (0.04) 0.07 (0.05) 0.623
Moderate to severe symptoms of depression 491 126 (25.4) 90 (27.7) 36 (21.7) 0.157
Social support (SD) 496 3.1 (1.2) 2.9 (1.2) 3.6 (0.9) B0.001
Anxiety disorder 490 23 (4.7) 17 (5.2) 6 (3.6) 0.504
*Compares detained vs. not detained. Significance defined as pB0.05, and marked in bold.
Table 3. Experiences associated with police detention among prisoners in Kyrgyzstan and Azerbaijan, accounting for official and
unofficial detention
Detentions and related events
(year before current incarceration)
Valid
N
Total
n (%)
Official detentiona
n (%)
Unofficial detentiona
n (%)
Country KYR AZ KYR AZ KYR AZ KYR AZ
Detained 355 496 183 (51.5) 169 (33.9) 182 (51.5) 169 (33.9) 76 (21.4) 35 (7.0)
Mean number (SD) 352 496 3.1 (4.7) 2.4 (2.3) 1.4 (1.3) 1.8 (1.3) 4.8 (6.2) 1.5 (1.0)
Experienced withdrawal during a detention
(among those using drugs at time of detention)
155 91 27 (17.4) 25 (27.5) 24 (17.0) 22 (25.6) 15 (21.7) 9 (39.1)
ART interrupted during detention
(among those detained while on ART)
6 0 2 (33.3) 0 2 (33.3) 0 2 (50.0) 0
OAT interrupted during detention
(among those detained while on OAT)
14 0 6 (42.9) 0 6 (46.2) 0 4 (44.4) 0
Had restricted access to ART, TB medication and/or OAT used
as a means to extract a confession during a detention
(among those on ART, TB, OAT)
78 55 20 (25.6) 1 (0.2) 16 (25.8) 0 13 (28.9) 1 (7.1)
aPercent of those reporting for whom it is applicable. KYR, Kyrgyzstan; AZ, Azerbaijan; ART, antiretroviral therapy; TB, tuberculosis; OAT, opioid
agonist therapy; SD, standard deviation.
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43% of the variance in the outcome in Kyrgyzstan and 17%
in Azerbaijan. Our results confirm and further clarify the
hypothesized relationship between detention and HIV risk-
taking behaviours.
Effects of detention on within prison drug injection in
Kyrgyzstan
Current WPDI was measured only among our participants in
Kyrgyzstan, but it is a crucial outcome variable to consider in
order to further confirm and clarify the relationship between
police detention and HIV risk-taking behaviours within prison,
which is an especially high risk behaviour. WPDI is a beha-
vioural outcome that measures current injection within
the high-risk prison environment and therefore introduces
temporal order to our self-reported cross-sectional data.
Arguably, if our results from the multi-group analysis reported
above are replicated with a conceptually stronger outcome
measure, the generalizability of the mediated relationship
between police detention and HIV risk behaviours would gain
in credibility.
Thus, we ran a similar path model to the one we
reported for both countries: with detention variables as
predictors, addiction severity as a mediator, and WPDI as
the outcome measure of HIV risk behavior. The final model
presented in Figure 2 for the Kyrgyzstan sub-analysis is a full
mediation model (X20.44, p0.81; GFI1.00; CFI1.00;
RMSEA0.00; PCLOSE0.91) that shows addiction severity
mediating the effect of detention on WPDI. Official and
unofficial detention were both significant correlates of
addiction severity with a similar magnitude, and had equal
indirect effects on WPDI (see Table 7). Because WPDI is a
dichotomous outcome measure, we followed a statistical
solution for mediation analysis with dichotomous variables,
recommended by MacKinnon and Dwyer [44,45].
Discussion
The data presented here draw attention to the role of
policing practices and police harassment in driving the spread
of HIV, addressing a major structural challenge to HIV pre-
vention in countries of the FSU in the Eastern European
and Central Asian region, where HIV incidence and mortality
continue to increase. Kyrgyzstan’s and Azerbaijan’s HIV epi-
demic, like those in neighbouring Eastern European and
Central Asian countries, is closely intertwined with substance
use and criminal sanctions against PWID [4]. PWID comprise
one-third of the prison population in these two countries
[29,30] and police harassment is common, but this study is
the first to examine the impact of policing behaviours on
negative health consequences in this region. Our results are
consistent with an emerging body of literature that attests
to law enforcement as a major roadblock to scaling-up HIV
prevention interventions both in the region [4,27], and
globally [18,4648]. Insights drawn here, from the only
scientifically rigorous biobehavioural surveys among prison-
ers in two FSU countries, provide the first evidence of the
effect of policing on concentrating and promulgating HIV risk-
taking within prisons. These findings highlight the important
role that police might play in HIV prevention and point to the
urgent need for changing the role of the police, including
Table 4. Correlations among the variables used in the path analysis
Measure 1 2 3 4 5 6 7
1. Official detention 
2. Unofficial detention 0.19* 
3. Addiction severity 0.08* 0.19* 
4. HIV risk 0.01 0.12* 0.55* 
5. Anxiety 0.10* 0.03 0.11* 0.06 
6. Depression 0.03 0.12* 0.12* 0.02 0.58* 
7. Alcohol use disorder 0.04 0.20* 0.20* 0.09* 0.05 0.24* 
8. Social Support 0.12* 0.04 0.02 0.21* 0.05 0.17* 0.03
*pB0.01.
Table 5. Significant covariates in the final path modela
Control variable Criterion variable B (SE) C.R. Beta
Anxiety Addiction severity 0.01 (0.00) 3.25 0.11
Social support HIV risk 3.5 (0.48) 7.23 0.20
aAll coefficients are significant at pB0.01.
Drug Addiction
Severity
Unofficial 
Detention
0.66/0.42
HIV Risk
0.19/0.14
Multi-group model for
Kyrgyzstan and Azerbaijan
R2=0.43/0.17
Figure 1. Multi-group results for mediation analysis. Country
moderated the relationship between unofficial detention and HIV
risk: Direct effect from unofficial detention to HIV risk was
significant (0.17) for KYR and not significant for AZ (0.02). Overall
model fit: X2.435; df2; p0.805; Root Mean Square Error of
Approximation (RMSEA) RMSEA0.000 (PCLOSE0.911); Com-
parative Fit Index (CFI) CFI1.00; Goodness of Fit Index (GFI)
GFI0.999. Multi-group results in figure correspond to Table 2. The
results (of multiple regression) showed that country moderated the
relationship between unofficial detention and HIV risk: Direct effect
from unofficial detention to HIV risk was significant (0.17) for KYR
and not significant for AZ (0.02). KYR, Kyrgyzstan; AZ, Azerbaijan.
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structural changes in policing practices, to reduce police
harassment of PWID who spend considerable time in prison
and remain the primary drivers of HIV in the region.
Our analyses disentangle the mediating and moderating
relationships between police detention, addiction severity
and HIV risk and demonstrate the importance of performing
moderated mediation analyses to account for data complex-
ity, as well as for revealing often surprising relationships in
the data. Detention had an indirect effect on HIV risk,
mediated by addiction severity, with more detentions
associated with higher addiction severity  in turn correlating
with increased HIV risk. This pattern suggests that police
selectively target PWID with higher addiction severity. Rather
than target them for arrest, police should align their practices
with public health and steer them toward evidence-based
treatment with methadone or buprenorphine, both of which
reduce addiction severity and HIV risk-taking behaviours [49],
and help avoid incarceration. Alternatively, if OAT is not
available or PWID are not injecting opioids, they can
encourage use of NSP, which also reduces HIV risk [50].
Moreover, these patterns hold for both Azerbaijan and
Kyrgyzstan, pointing to a wider and consistent trend throughout
the region. Rates of detention in our sample were high, with
over half and a third of participants in Kyrgyzstan and
Azerbaijan, respectively, reporting detention in the year before
incarceration. Country acts as a moderator in the model and
the effect of police detention on HIV risk is stronger for
Kyrgyzstan, where over one-third of those accessing services
reported disruption in ART, OAT or NSP access as a result of
detention. This is consistent with data showing that police
detention and the fear of police harassment impedes PWID’s
capacity for HIV risk reduction [12,51], leading to sharing
of injection equipment and decreased engagement in harm
reduction services.
These data are the first to draw a health distinction
between unofficial (extrajudicial and therefore deemed
harassment) and official (judicial and potentially with just
cause) detention. While both unofficial and official detention
contribute to increased HIV risk-taking behaviours, mediated
by addiction severity, unofficial detention is more strongly
associated with the outcome. Police harassment here is a
correlate of addiction severity, which mediates its effect on
HIV risk behaviour. It is well established that community
policing is often inconsistent with established guidelines,
interfering with harm reduction programmes and undermining
health and human rights [10]. The negative health effects of
unofficial detention are consistently stronger than those for
official detention in Kyrgyzstan (see Table 3). The heavy-
handed role of policing in the region is embedded in a
historical context [27], where interventions for PWID in the
Soviet Union were limited to non-evidence based and
unethical forced detox, treatment with neuroleptics, labour
camps, and social isolation [2]. This legacy is now evident
in the harassment of PWID for possessing small amounts of
drugs for personal use, and arrest of methadone patients
outside of addiction treatment clinics [52]. It is no surprise,
then, that police harassment of PWID, who are at heightened
risk for blood-borne infections, is a structural factor con-
tributing to HIV transmission in the community.
Our data from Kyrgyzstan are the first to provide a glimpse
into the role of police harassment in promoting onward HIV
transmission not only in the community, but also within the
extraordinarily high-risk prison environment where injection
equipment is scarce and associated with heightened trans-
mission risk. In Kyrgyzstan, detention is fully mediated by
addiction severity on current WPDI. This is especially per-
tinent given that WPDI is extremely common in PWID [30].
Our results suggest that police target PWID and that such
Table 6. Direct, indirect and total effects among the variables in the multi-group model
Direct effects Indirect effects Total effects
Variables Criterion
Beta (SE) Beta (SE) Beta (SE)
Predictor Country KYR AZ KYR AZ KYR AZ
Unofficial detention Addiction severity 0.19a (0.08) 0.14 (0.06)   0.19 (0.08) 0.14 (0.06)
HIV risk   0.12 (0.05)* 0.06 (0.03)* 0.12 (0.05) 0.06 (0.03)*
Addiction severity HIV risk 0.65 (0.06)* 0.42 (0.07)*   0.65 (0.06) 0.42 (0.07)*
aAll coefficients in the model are significant at pB0.01. *Significant difference between two countries at pB0.01. KYR, Kyrgyzstan; AZ,
Azerbaijan.
Drug Addiction
Severity
Unofficial 
Detention
Official 
Detention
0.24
0.11
0.48 WPDI
0.12
Kyrgyzstan within prison drug injection
R2=0.23
Figure 2. Path model for unofficial and official detention effects
on within-prison drug injection (WPDI) mediated by addiction
severity. All paths are significant at pB0.01. Indirect effects were
tested via AMOS bootstrapping procedure with 4000 bootstrap
samples and bias-corrected confidence intervals. Overall model fit:
X20.435; df2; p0.805; Root Mean Square Error of Approx-
imation (RMSEA) RMSEA0.000 (PCLOSE0.911); Comparative Fit
Index (CFI) CFI1.00; Goodness of Fit Index (GFI) GFI0.999. Both
official and unofficial detention for KYR subset only, due to current
WPDI. Standardized bootstrap indirect effects. Unofficial to
WPDI0.06, p0.05. Official to WPDI0.06, p0.05.
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harassment may result in the increase in HIV risk-taking
behaviours, primarily because of the continued drug use
within prisons. It is well established that treating addiction
within criminal justice settings is key, including implementing
OAT and effectively transitioning them to the community [4],
which will not only reduce HIV transmission, but improve
HIV- and non-HIV-related health outcomes [5358]. Even
though our decision to measure and compare official and
unofficial detention allowed us to more closely examine the
relationship between detention, addiction severity and HIV
risk-taking behaviours, it is important to note that both types
of detention may constitute police harassment, including
those instances of official detention that resulted in the
current incarceration.
Though meaningful findings were gleaned from our
research, several limitations remain. First, the cross-sectional
design restricts our ability to infer a causal nature of the
observed relationships and limits the findings to correlations.
The study’s focus on distinct time periods of detention
experiences and health risk behaviours, however, lessen
some of these concerns by outlining a hypothesized causal
mechanism that can be subsequently elucidated with long-
itudinal design. It is important to note that the current WPDI
measure for the Kyrgyzstan sample has allowed us to address
and clarify temporal ordering in our cross-sectional data.
Conversely, our inability to include a similar measure in
Azerbaijan due to obligations to report drug use to prison
department is a limitation. Clearly, further research employ-
ing longitudinal designs that would allow establishing causa-
lity and likely result in more meaningful mediating and
moderating relationships is warranted. Also, we relied on
self-reported measures for several parameters, including for
opioid injection, but these were validated measures and the
sheer magnitude suggest that they represent conservative
amounts of drug use. This could have resulted in under-
reporting of health risk behaviours due to social desirability
bias. Self-reporting may also result in underreporting of
detention experiences, although the observed high rates of
detention in our study reduce this concern. Another potential
limitation that may restrict interpretation and accuracy is
recall bias, since participants had to report on remote pre-
incarceration behaviours and experiences. Notwithstand-
ing these limitations, our findings point to a conceivable
mechanism of the effects of policing practices on the health
of PWID who interface with criminal justice system and lay
the foundation for future research to replicate and expand
these findings, as well as for future strategies to engage
police enforcement in advancing individual and public health.
Conclusions
Given the police’s role in shaping HIV transmission, it is now
necessary to shift focus to best-practice implementation
strategies to influence HIV prevention. While most HIV pre-
vention has been focused on individual changes in behaviour,
our data provide empirical support for the environmental
influence of policing on HIV risk. PWID exist in complex risk
environments where factors interact to produce drug-related
harm [60]. Accordingly, successful biobehavioural interven-
tions delivered to PWID, including OAT expansion, must
address environmental factors, which can include intimida-
tion, violent victimization, marked social stratification, and
stigmatization of people with or at risk for HIV, and people
who receive drug treatment and OAT in particular [60,61].
Therefore, police interaction with PWID should be harnessed
and aligned with HIV prevention to implement evidence-
based harm reduction practices including referral to NSPs,
supervised injection sites, and OAT [10]. There is new
evidence that targeted police training in Kyrgyzstan that
focuses on HIV prevention is associated with improved public
health knowledge [18]. Furthermore, making positive health
outcomes an incentive for assessing police performance is
key to increasing law enforcement’s concern for health.
Fostering partnerships between law enforcement and the
public health sector is paramount to ensuring improved
health outcomes among marginalized populations [62].
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